Clinical Trial Update: Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updating safety and effectiveness of allogeneic umbilical cord blood-derived mesenchymal stem cells in patients with recessive dystrophic epiderm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cells

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: COMPLETED